Advanced search
Publication Cover
Psychology, Health & Medicine Volume 12, 2007 - Issue 2
Submit an article Journal homepage
408
Views
31
CrossRef citations to date
0
Altmetric
Original Articles

Factor structure of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4)

Colin R. Martin Faculty of Medicine Faculty of Medicine, Chinese University of Hong Kong, Hong KongCorrespondence[email protected]
&
Richard Allan Craven, Harrogate and Rural District Primary Care Trust, Harrogate, UK
Pages 126-134 | Published online: 19 Feb 2007

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Colin R. Martin & Mick Fleming. (2019) Evidence for the continuum-severity model of psychosis through scrutiny of the architecture of symptoms associated with schizophrenia. Psychosis 11:1, pages 42-53.
Read now
Yeon-Jeong Shin, Yo-Han Joo & Jong-Hoon Kim. (2016) Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia. Neuropsychiatric Disease and Treatment 12, pages 1411-1417.
Read now
Jong-Hoon Kim, Seul Lee, Ah-Young Han, Kyungwook Kim & Jinyoung Lee. (2015) Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia. Neuropsychiatric Disease and Treatment 11, pages 2041-2048.
Read now
Helen Walker, Lindsay Tulloch, Mark Ramm, Emma Drysdale, Alan Steel, Colin Martin, Gary MacPherson & Jennifer Connaughton. (2013) A randomised controlled trial to explore insight into psychosis; effects of a psycho-education programme on insight in a forensic population. The Journal of Forensic Psychiatry & Psychology 24:6, pages 756-771.
Read now
Po-Ju Kuo, Hui-Ing Ma, Chien-Cheng Kuo, Wei-Che Huang & Ming-Shun Chung. (2009) Factor analysis of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) Chinese version and related factors. International Journal of Psychiatry in Clinical Practice 13:4, pages 278-284.
Read now

Articles from other publishers (26)

Zahra Hoseinipalangi, Zahra Golmohammadi, Sima Rafiei, Fatemeh Pashazadeh Kan, Hossein Hosseinifard, Sepideh Rezaei, Saba Ahmadi, Niloofar Ahmadi, Samira Raoofi, Farnaz Aghajani, Afsaneh Dehnad, Hosein Shabaninejad, Sepideh Aghalou, Hamide Shabani & Ahmad Ghashghaee. (2022) Global health-related quality of life in schizophrenia: systematic review and meta-analysis. BMJ Supportive & Palliative Care 12:2, pages 123-131.
Crossref
István Laszlovszky, Ágota Barabássy & György Németh. (2021) Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety. Advances in Therapy 38:7, pages 3652-3673.
Crossref
Lindsey Gilling McIntosh, Sarah Janes, Suzanne O'Rourke & Lindsay D.G. Thomson. (2021) Effectiveness of psychological and psychosocial interventions for forensic mental health inpatients: A meta-analysis. Aggression and Violent Behavior 58, pages 101551.
Crossref
Kristiina Puolakka & Anneli Pitkänen. (2019) Effectiveness of psychosocial interventions on quality of life of patients with schizophrenia and related disorders: A systematic review. Archives of Psychiatric Nursing 33:5, pages 73-82.
Crossref
Juan Ignacio Arraras, Berta Ibañez, Nahia Pereda, Sergio Iribarren & Izaskun Basterra. (2019) The association of clinical insight and depression with quality of life in schizophrenia. Psychiatry Research 279, pages 350-352.
Crossref
Seon-Cheol Park, Mi Young Choi, Jina Choi, Eunjung Park, Ha Jin Tchoe, Jae Kyung Suh, Young Hoon Kim, Seung Hee Won, Young-Chul Chung, Kyung-Yeol Bae, Sang-Kyu Lee, Chan Mi Park & Seung-Hwan Lee. (2018) Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis. Clinical Psychopharmacology and Neuroscience 16:4, pages 361-375.
Crossref
J.I. Arraras, B. Ibañez, I. Basterra, N. Pereda, M. Martin & S. Iribarren. (2018) Determinants of Quality of Life in Spanish outpatients with schizophrenia spectrum disorders. The European Journal of Psychiatry 32:3, pages 113-121.
Crossref
Michaela Sturgeon, Nichola Tyler & Theresa A. Gannon. (2018) A systematic review of group work interventions in UK high secure hospitals. Aggression and Violent Behavior 38, pages 53-75.
Crossref
Chia-Ting Su, Ai-Lun Yang & Chung-Ying Lin. (2017) Comparing two schizophrenia-specific quality of life instruments in institutionalized people with schizophrenia. Psychiatry Research 258, pages 274-282.
Crossref
Sung-Jin Kim, Jung-Min Kim, Joo-Cheol Shim, Beom-Joo Seo, Sung-Soo Jung, Jeoung-Whan Ryu, Young-Soo Seo, Yu-Cheol Lee, Jung-Joon Moon, Dong-Wook Jeon, Kyoung-Duck Park & Do-Un Jung. (2017) The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity. Clinical Psychopharmacology and Neuroscience 15:3, pages 261-268.
Crossref
Eun-Chan KangSung-Jin KimYoung-Soo SeoSung-Soo JungBeom-Joo SeoJeoung-Whan RyuJoo-Cheol ShimJung-Joon MoonDong-Wook JeonKyoung-Duck ParkDo-Un Jung. (2017) The Korean Version of the Schizophrenia Cognition Rating Scale: Reliability and Validity. Psychiatry Investigation 14:2, pages 141.
Crossref
Chia-Ting Su, Ai-Lun Yang & Chung-Ying Lin. (2017) The Construct of the Schizophrenia Quality of Life Scale Revision 4 for the Population of Taiwan. Occupational Therapy International 2017, pages 1-11.
Crossref
Viktor Isjanovski, Andromahi Naumovska, Dimitar Bonevski & Antoni Novotni. (2016) Validation of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) Among Patients with Schizophrenia. Open Access Macedonian Journal of Medical Sciences 4:1, pages 65-69.
Crossref
Diana Rofail, Antoine Regnault, Stéphanie le Scouiller, Carmen Galani Berardo, Daniel Umbricht & Ray Fitzpatrick. (2015) Health-related quality of life in patients with prominent negative symptoms: results from a multicenter randomized Phase II trial on bitopertin. Quality of Life Research 25:1, pages 201-211.
Crossref
John M. Kane, Stephen Zukin, Yao Wang, Kaifeng Lu, Adam Ruth, Krisztián Nagy, István Laszlovszky & Suresh Durgam. (2015) Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia. Journal of Clinical Psychopharmacology 35:4, pages 367-373.
Crossref
Chia-Yeh Chou, Tsung-Tsair Yang, Mi-Chia Ma, Po-Ren Teng & Tsai-Chun Cheng. (2015) Psychometric validations and comparisons of schizophrenia-specific health-related quality of life measures. Psychiatry Research 226:1, pages 257-263.
Crossref
Ivana Simić-Medojević & Marija Burgić-Radmanović. (2015) Quality of life of schizophrenic patients with or without depot neuroleptics. Scripta Medica 46:1, pages 60-65.
Crossref
Mijeong LimMinyoung SimSungun ChaeWon Hye LeeJoonho NaDaeho Kim. (2015) Stress Coping Strategies and Quality of Life in Patients with Schizophrenia. Journal of Korean Neuropsychiatric Association 54:2, pages 181.
Crossref
Frédéric Rouillon, Lars Eriksson, Benjaminas Burba, Jiri Raboch, Georgios Kaprinis & Andreas Schreiner. (2013) Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). Acta Neuropsychiatrica 25:5, pages 297-306.
Crossref
Helen Walker, Lindsay Tulloch & Colin Martin. (2012) Are they worth it? A systematic review of QOL instruments for use with mentally disordered offenders who have a diagnosis of psychosis. The British Journal of Forensic Practice 14:4, pages 252-268.
Crossref
Nur Akmar Taha, Mohamed Izham Ibrahim, Ab Fatah Rahman, Asrul Akmal Shafie & Abdul Hamid Rahman. (2012) Validation of the Schizophrenia Quality of Life Scale Revision 4 among Chronic Schizophrenia Patients in Malaysia. Value in Health Regional Issues 1:1, pages 82-86.
Crossref
Rosario de Arce Cordón, Evelin Eding, Joao Marques-Teixeira, Vihra Milanova, Elmars Rancans & Andreas Schreiner. (2011) Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). European Archives of Psychiatry and Clinical Neuroscience 262:2, pages 139-149.
Crossref
P Ronan. (2011) A case study exploration of the value of acupuncture as an adjunct treatment for patients diagnosed with schizophrenia: results and future study design. Journal of Chinese Integrative Medicine 9:5, pages 503-514.
Crossref
C. R. Martin & M. Fleming. 2010. Handbook of Disease Burdens and Quality of Life Measures. Handbook of Disease Burdens and Quality of Life Measures 3607 3624 .
Ariane K. Kawata & Dennis A. Revicki. (2007) Reliability and validity of the social integration survey (SIS) in patients with schizophrenia. Quality of Life Research 17:1, pages 123-135.
Crossref
Po-Ju Kuo, Mei-Jin Chen-Sea, Ru-Band Lu, Ming-Shun Chung, Chien-Cheng Kuo, Wei-Che Huang & Hui-Ing Ma. (2007) Validation of the Chinese version of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) in Taiwanese patients with schizophrenia. Quality of Life Research 16:9, pages 1533-1538.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.